Drug Pricing

Prescription drug prices continue to rise, threatening to make vital therapies unaffordable for many patients. Kaiser Permanente believes it is time for a new legal and policy landscape for drug pricing that rewards innovation and discovery, but also provides medicines at prices patients and the health care system can afford.

Featured Drug Pricing Content

Building a bigger table for a more equitable drug development system
Biosimilars at Kaiser Permanente
The Medicaid Drug Rebate Program and the impact of “best price” rules
Drug policy 101: Pharmaceutical marketing tactics
Load More

Drug Policy 101 Series

Drug policy 101: Pharmaceutical marketing tactics
Drug policy 101: Breaking down different types of drug products
Drug policy 101: The state of the pharmaceutical evidence base
Drug policy 101: Drug patents
Load More

Drug Pricing Forum

This forum brought together leaders from across sectors together in Washington, D.C. to discuss the drug pricing landscape and elevate effective policy solutions.

View Addressing High Drug Pricing forum

Fast Facts

1 in 4

1 in 4 people in the U.S. have difficulty affording their medication 1

cost of medication

3 in 10 adults  reported skipping their medications because of cost in the past year 2

Half of drug costs

Specialty drugs are projected to make up 50% of all U.S. pharmacy costs even though they account for a small percentage of prescriptions 3